Kurz gefasst
Leitlinie in der Zeitschrift JAMA, erschienen am 10.06.2025. Verfasst von Sally Hopewell und 38 weiteren Autor:innen. Beteiligte Einrichtung: Oxford Clinical Trials Research Unit, Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom. Hauptthemen laut MEDLINE: Checklist, Publishing, Randomized Controlled Trials as Topic, Research Report. Die Arbeit wurde bisher 435-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Importance Well-designed and properly executed randomized trials are considered the most reliable evidence on the benefits of health care interventions. However, there is overwhelming evidence that the quality of reporting is not optimal. The CONSORT (Consolidated Standards of Reporting Trials) statement was designed to improve the quality of reporting and provides a minimum set of items to be included in a report of a randomized trial. CONSORT was first published in 1996, then updated in 2001 and 2010. Herein, we present the updated CONSORT 2025 statement, which aims to account for recent methodological advancements and feedback from end users. Observations We conducted a scoping review of the literature and developed a project-specific database of empirical and theoretical evidence related to CONSORT to generate a list of potential changes to the checklist. The list was enriched with recommendations provided by the lead authors of existing CONSORT extensions (harms, outcomes, nonpharmacological treatment), other related reporting guidelines (Template for Intervention Description and Replication [TIDieR]), and recommendations from other sources (eg, personal communications). The list of potential changes to the checklist was assessed in a large, international, online, 3-round Delphi survey involving 317 participants and discussed at a 2-day online expert consensus meeting of 30 invited international experts. We have made substantive changes to the CONSORT checklist. We added 7 new checklist items, revised 3 items, deleted 1 item, and integrated several items from key CONSORT extensions. We also restructured the CONSORT checklist, with a new section on open science. The CONSORT 2025 statement consists of a 30-item checklist of essential items that should be included when reporting the results of a randomized trial and a diagram for documenting the flow of participants through the trial. To facilitate implementation of CONSORT 2025, we have also developed an expanded version of the CONSORT 2025 checklist, with bullet points eliciting critical elements of each item. Conclusions and Relevance Authors, editors, reviewers, and other potential users should use CONSORT 2025 when writing and evaluating manuscripts of randomized trials to ensure that trial reports are clear and transparent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Oxford Clinical Trials Research Unit, Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom.
- Department of Medicine, Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada.
- UK EQUATOR Centre, Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom.
- Centre for Evidence-Based Medicine Odense and Cochrane Denmark, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
- Open Patient Data Explorative Network, Odense University Hospital, Odense, Denmark.
- Centre for Journalology, Clinical Epidemiology Programme, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Zitieren
APA
Hopewell, S., Chan, A. W., Collins, G. S., Hróbjartsson, A., Moher, D., Schulz, K. F., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., Bhandari, N., Butcher, N. J., Campbell, M. K., Chidebe, R. C. W., Elbourne, D., Farmer, A., Fergusson, D. A., Golub, R. M., Goodman, S. N., …, & Boutron, I. (2025). CONSORT 2025 Statement. JAMA, 333(22), 1998. https://doi.org/10.1001/jama.2025.4347
Vancouver
Hopewell S, Chan AW, Collins GS, Hróbjartsson A, Moher D, Schulz KF, et al. CONSORT 2025 Statement. JAMA. 2025;333(22):1998. doi:10.1001/jama.2025.4347
BibTeX
@article{Hopewell2025,
author = {Hopewell, Sally and Chan, An-Wen and Collins, Gary S and Hróbjartsson, Asbjørn and Moher, David and Schulz, Kenneth F and Tunn, Ruth and Aggarwal, Rakesh and Berkwits, Michael and Berlin, Jesse A and Bhandari, Nita and Butcher, Nancy J and Campbell, Marion K and Chidebe, Runcie C W and Elbourne, Diana and Farmer, Andrew and Fergusson, Dean A and Golub, Robert M and Goodman, Steven N and Hoffmann, Tammy C and Ioannidis, John P A and Kahan, Brennan C and Knowles, Rachel L and Lamb, Sarah E and Lewis, Steff and Loder, Elizabeth and Offringa, Martin and Ravaud, Philippe and Richards, Dawn P and Rockhold, Frank W and Schriger, David L and Siegfried, Nandi L and Staniszewska, Sophie and Taylor, Rod S and Thabane, Lehana and Torgerson, David and Vohra, Sunita and White, Ian R and Boutron, Isabelle},
title = {CONSORT 2025 Statement},
journal = {JAMA},
year = {2025},
volume = {333},
number = {22},
pages = {1998},
doi = {10.1001/jama.2025.4347}
}
EUVIMED